Sign in
VICP Stock Price, Chart, Stats & News
Vicapsys Life Sciences, Inc.
Save
Vicapsys Life Sciences, Inc. (VICP) does not currently pay a dividend.
46.94M
Market cap
–
Current P/E
–
Forward P/E
VICP chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Vicapsys Life Sciences, Inc. is primarily focused on bringing its exclusive VICAPSYN product to market, guiding it through development and commercialization. This product's intended application is within the field of transplantation, specifically for various transplant therapies and associated stem-cell uses. Additionally, the company is advancing the development of VYBRIN, a compound based on CXCL12.
Similar securities
Based on sector and market capitalization
Report issue